about
SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat.Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.Potential therapeutic benefits of strategies directed to mitochondria.Nutraceuticals and headache: the biological basis.The migraine-ischemic stroke relation in young adults.An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine.Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use.New migraine preventive options: an update with pathophysiological considerations.Future pharmacologic targets for acute and preventive treatments of migraine.Postictal headache and migraine.Selected confirmed, probable, and exploratory migraine biomarkers.Migraine and ischemic stroke: a debated question.Prevalence and risk of migraine headaches in adult fragile X premutation carriersIncreased migraine risk in osteoporosis patients: a nationwide population-based studyScreening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean MigraineursKynurenines and headache.Polytherapy for migraine prophylaxis.Pathogenesis of migraine: role of neuromodulators.Pharmacological treatment of chronic non-cancer pain in pediatric patients.A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11Isolated familial hypomagnesaemia with novel neurological features: causal link or chance concurrence?Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis.Transcranial direct current stimulation reveals inhibitory deficiency in migraine.Low brain intracellular free magnesium in mitochondrial cytopathies.Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study.Slow cortical potentials in migraine families.Visual contrast processing in migraine.Electroencephalographic abnormalities in aseptic meningitis and noninfectious headache. A comparative study.Effects of pregnancy on slow cortical potentials in migraine patients and healthy controls.Disease duration of episodic migraine correlates with modified amplitudes and habituation of contingent negative variation.Evaluation of carotid intima-media thickness in children with migraine: a marker of subclinical atherosclerosis.Patterns of functional brain organization and migraine.What kind of habituation is impaired in migraine patients?Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity?Non-Pharmacological Approaches for Migraine.Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.The Role of Magnesium in Neurological Disorders.
P2860
Q30912250-B38C09DD-8B5D-49F3-845D-5DCC2BD2766EQ30987223-6F0933DC-82F9-4FD4-9E7C-AF2B234B369FQ34117168-C9FCF2D2-E9C5-4F71-9138-5F31F379EF4BQ34166931-F488106E-D97D-4B30-89A6-EF9F0A7CB58DQ34424023-DA1C7A5D-0845-4D68-84BE-CE0003918FE8Q34455231-3EE36486-276B-42FC-BEDF-A83392453416Q34517292-48FB0B70-9825-41E7-991D-B0EB109C79A0Q35075798-246E9A7E-D9D5-4AC3-8961-8B42583EA1B0Q36106970-8BC862BF-EA94-42A3-A46C-E289DBE98090Q36462146-5C907228-76A0-4B5C-AD78-9A37694E7C20Q36546368-EF9128FC-9BCF-421D-9682-5DE14371C956Q37156443-AF37D5A8-F752-463C-8C45-C9A5C4B586F0Q37191145-BB2F137B-18EB-44E8-AA92-324FADA584B1Q37194880-7F5E233F-8AEC-47ED-A9F0-9853ED71C940Q37203235-FBD28919-CC07-4940-8E9B-10CEBBA670CEQ37885234-0A372505-CE20-4AE4-880D-0470892FFF56Q38014301-52F51743-7716-4E55-BE0E-FFED8F3A597EQ38016505-28B7BBCF-0578-4D58-BEED-02ABB8F68B0FQ38258949-ED8CF4FE-DFEE-4A0F-8BC4-E38548107A03Q39371120-00027B9A-8B01-439F-AD1A-3F143F4F21FEQ39405242-25678BEF-9BAC-42B3-9B27-58C77B7ED481Q41815748-E68640BD-AB42-4603-8F0B-549A22DB6909Q42607264-E73AE215-A911-4E4D-B2A7-BF99DE3253D1Q43735977-C2CD34AC-837D-48C6-A9AB-0B8034C1D1A9Q43882927-1D6AE4EB-96AD-4AED-BB06-DB8D7C45D50EQ48170292-7D298B06-6855-4330-BAAD-57454188E204Q48212101-0E8FF554-89FB-4695-866E-BB96357483C3Q48587441-CCFCBE0A-1DE3-48C6-802D-E2BFB73163BAQ48916121-4CCD3FC6-24E8-4B4F-920C-92EE654BAE31Q48916134-573CDE8D-3736-463F-8027-613734223B08Q49043317-63A978BF-5179-4C5E-8F0A-D1FE66DE02AEQ49089106-68DFD900-27C3-450D-A157-8F401260A05AQ50621353-A80B0762-069D-43AB-8C8B-86CF52311997Q51668026-7690BF0B-7705-40B3-8C7A-9B01DD1F201BQ52090356-27047BC5-3205-42FA-B77A-A6E19F63C479Q52100948-D34E61B3-A97E-44A0-B8C2-0EA0DAD2261EQ52168291-B2095F23-D755-4917-BE2D-23FC918D7223Q52332599-430EB4CC-B3D7-4524-AED3-1FB58F5410CAQ53407201-485D540A-6D19-4CDC-8E9E-79468F744C50Q55515107-AAB38FE8-A1A0-443F-82C1-73047B0DD13E
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Mitochondria, magnesium and migraine.
@en
type
label
Mitochondria, magnesium and migraine.
@en
prefLabel
Mitochondria, magnesium and migraine.
@en
P1476
Mitochondria, magnesium and migraine.
@en
P2093
P356
10.1016/0022-510X(95)00196-1
P577
1995-12-01T00:00:00Z